WARNER KING HUH

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. doi Consistency of in vitro chemoresponse assay results and population clinical response rates among women with endometrial carcinoma
    Warner K Huh
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Int J Gynecol Cancer 21:494-9. 2011
  2. ncbi Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix
    W K Huh
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 35249, USA
    Gynecol Oncol 83:370-7. 2001
  3. ncbi Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
    Warner K Huh
    University of Alabama at Birmingham, Birmingham, AL 35249, USA
    Gynecol Oncol 91:470-5. 2003
  4. ncbi Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience
    W K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Int J Gynecol Cancer 17:886-9. 2007
  5. doi The future of vaccines for cervical cancer
    Warner K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, 618 20th Street South, OHB Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 109:S48-56. 2008
  6. ncbi Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma
    David E Cohn
    Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, Ohio, USA
    Obstet Gynecol 109:1388-95. 2007
  7. doi Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
    Amanda Nickles Fader
    Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, USA
    Cancer 115:2119-27. 2009
  8. doi An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Amanda Nickles Fader
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic, Cleveland, OH, USA
    Gynecol Oncol 115:244-8. 2009
  9. ncbi Novel methods to treat and prevent human papillomavirus infection
    James E Kendrick
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 619 19th Street South, OHB 538 Birmingham, AL 35249 7333, USA
    Expert Rev Anti Infect Ther 4:593-600. 2006
  10. ncbi Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
    Cancer 107:1823-30. 2006

Detail Information

Publications58

  1. doi Consistency of in vitro chemoresponse assay results and population clinical response rates among women with endometrial carcinoma
    Warner K Huh
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Int J Gynecol Cancer 21:494-9. 2011
    ..The purpose of this investigation was to determine whether the patterns of in vitro tumor response rates as determined by ChemoFx are consistent with expected population response rates...
  2. ncbi Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix
    W K Huh
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 35249, USA
    Gynecol Oncol 83:370-7. 2001
    ..In this regard, bax is a pro-apoptotic molecule that also functions as a tumor suppressor. The purpose of this study was to evaluate bax as a gene therapeutic in the context of cervical cancer...
  3. ncbi Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
    Warner K Huh
    University of Alabama at Birmingham, Birmingham, AL 35249, USA
    Gynecol Oncol 91:470-5. 2003
    ..Our aim was to determine the outcomes of Stage I uterine papillary serous carcinoma (UPSC) patients with and without adjuvant therapy after comprehensive surgical staging...
  4. ncbi Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience
    W K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Int J Gynecol Cancer 17:886-9. 2007
    ....
  5. doi The future of vaccines for cervical cancer
    Warner K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, 618 20th Street South, OHB Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 109:S48-56. 2008
    ..Future applications of existing virus-like particle-based vaccines are also discussed...
  6. ncbi Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma
    David E Cohn
    Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, Ohio, USA
    Obstet Gynecol 109:1388-95. 2007
    ..To estimate the costs and outcomes of various strategies used for the management of grade 1 endometrial cancer...
  7. doi Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
    Amanda Nickles Fader
    Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, USA
    Cancer 115:2119-27. 2009
    ..A study was undertaken to determine recurrence patterns and survival outcomes of stage I uterine papillary serous carcinoma (UPSC) patients...
  8. doi An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Amanda Nickles Fader
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic, Cleveland, OH, USA
    Gynecol Oncol 115:244-8. 2009
    ..However, clinicopathologic risk factors for recurrence are not well understood. This study was undertaken to define the prognostic factors for recurrence and survival in patients with early-stage UPSC...
  9. ncbi Novel methods to treat and prevent human papillomavirus infection
    James E Kendrick
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 619 19th Street South, OHB 538 Birmingham, AL 35249 7333, USA
    Expert Rev Anti Infect Ther 4:593-600. 2006
    ..A host of various vaccine techniques are currently being developed and tested and, if effective, will have a significant impact on the incidence of cervical dysplasia and carcinoma...
  10. ncbi Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
    Cancer 107:1823-30. 2006
    ..The purpose of the current study was to determine the potential therapeutic role of lymphadenectomy in women with endometrioid corpus cancer...
  11. doi The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rodney P Rocconi
    Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA
    Gynecol Oncol 114:242-5. 2009
    ..To determine if the timing of normalization of CA-125 levels during primary chemotherapy for epithelial ovarian cancer (EOC) could predict survival...
  12. ncbi LUMA cervical imaging system
    James E Kendrick
    University of Alabama at Birmingham, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Birmingham, AL 35249 7333, USA
    Expert Rev Med Devices 4:121-9. 2007
    ..The US FDA approved this device in March 2006 to be used to enhance the sensitivity of colposcopic examinations of women with abnormal cervical cytology, in an effort to further reduce the incidence of cervical cancer...
  13. ncbi New advances in vaccine technology and improved cervical cancer prevention
    Warner K Huh
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Obstet Gynecol 109:1187-92. 2007
    ....
  14. pmc Lynch syndrome in women less than 50 years of age with endometrial cancer
    Kellie S Matthews
    Division of Gynecologic Oncology and the Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Obstet Gynecol 111:1161-6. 2008
    ..To estimate the frequency of mismatch repair deficiencies associated with hereditary nonpolyposis colorectal cancer, or Lynch syndrome, in women less than age 50 with endometrial cancer...
  15. doi Evaluation of the interim analysis from the PATRICIA study group: efficacy of a vaccine against HPV 16 and 18
    Peter J Frederick
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 619 19th Street South, OHB 538, Birmingham, AL 35249 7333, USA
    Expert Rev Anticancer Ther 8:701-5. 2008
    ..The purpose of this review is to summarize PATRICIA, with a specific focus on the results of the interim analysis, and discuss the impact and implications of the findings...
  16. doi Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes
    Amanda Nickles Fader
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A 81, Cleveland, Ohio 44195, USA
    Gynecol Oncol 112:558-62. 2009
    ..To determine recurrence patterns and survival outcomes of stage II uterine papillary serous carcinoma (UPSC) patients treated by various modalities with an emphasis on carboplatin/paclitaxel-based chemotherapy (CT)+/-radiotherapy (RT)...
  17. doi Human papillomavirus infection: a concise review of natural history
    Warner K Huh
    Department of Obstetrics and Gynecology, University of Alabama Birmingham, Birmingham, Alabama, USA
    Obstet Gynecol 114:139-43. 2009
    ..This article highlights the natural history of oncogenic HPV infection of the cervix and the limitations that currently exist on the literature...
  18. doi The management of cervical intraepithelial neoplasia during pregnancy: is colposcopy necessary?
    Luisa A Wetta
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    J Low Genit Tract Dis 13:182-5. 2009
    ..Therefore, we sought to determine the incidence of cervical intraepithelial neoplasia (CIN) 2,3 in pregnant patients referred to a university colposcopy clinic...
  19. ncbi Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rodney P Rocconi
    University of Alabama at Birmingham, 35233, USA
    Oncologist 11:336-41. 2006
    ....
  20. ncbi Conservative management of stage I endometrial carcinoma after surgical staging
    J Michael Straughn
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Gynecol Oncol 84:194-200. 2002
    ..The aim of this study was to determine the outcomes of Stage I endometrial carcinoma patients who are managed without adjuvant radiation after comprehensive surgical staging...
  21. ncbi Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study
    Warner K Huh
    University of Alabama at Birmingham, Birmingham, Alabama 35233 7333, USA
    Am J Obstet Gynecol 190:1249-57. 2004
    ..The purpose of this study was to assess the in vivo optical detection of high-grade cervical intraepithelial neoplasia (2/3+) on the whole cervix with a noncontact, spectroscopic device...
  22. ncbi Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy
    J Michael Straughn
    University of Alabama at Birmingham, 35249, USA
    Gynecol Oncol 89:295-300. 2003
    ..The goal of this study was to determine the outcomes of stage IC endometrial carcinoma patients who are managed with and without adjuvant radiation therapy after comprehensive surgical staging...
  23. ncbi A case report of rhabdomyosarcoma of the uterus associated with uterine inversion
    Ashley S Case
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 South 19th Street, Old Hillman Building, Room 340, Birmingham, AL 35233, USA
    Gynecol Oncol 96:850-3. 2005
    ..This tumor is associated with a poor prognosis, especially in the adult population. Equally as rare are non-puerperal uterine inversions secondary to sarcomas...
  24. ncbi Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 97:387-94. 2005
    ..To assess the potential effectiveness and medical costs of three common strategies to manage Stage IB2 squamous cell carcinoma of the cervix (CXCA)...
  25. ncbi Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy
    Tyler O Kirby
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, OHB 538, 619 19th Street South, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 98:309-12. 2005
    ..To investigate the patterns of recurrence associated with superficial inguinal lymphadenectomy (SupIL) and vulvectomy for patients with Stage I/II vulvar cancer...
  26. doi Lipoxygenase pathway receptor expression in ovarian cancer
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36607, USA
    Reprod Sci 15:321-6. 2008
    ..To determine the expression of lipoxygenase (LOX) pathway receptors in ovarian cancer as a potential target for anti-LOX-based therapy...
  27. ncbi Primary extrarenal rhabdoid tumor of the ovary. A case report
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 340 Old Hillman Building, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Reprod Med 48:283-6. 2003
    ..Although extrarenal rhabdoid tumors have been documented at multiple extrarenal sites, to our knowledge no primary ovarian cases have been reported...
  28. ncbi Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy
    Jacob M Estes
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama Birmingham, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Am Coll Surg 203:527-32. 2006
    ..Our goal was to determine the morbidity, disease-free survival, and overall survival of patients with bowel resection at primary cytoreductive surgery for advanced epithelial ovarian carcinoma in the era of platinum and taxane chemotherapy...
  29. ncbi Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report
    Whitney A Spannuth
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 619 19th Street South, Old Hillman Building Room 538, Birmingham, AL 35294 7333, USA
    Gynecol Oncol 98:155-7. 2005
    ..Although mature cystic teratoma is the most common tumor of the ovary, squamous cell carcinoma arising from a mature teratoma is a rare event. Prognosis depends on clinical stage, grade, and recently described mode of tumor infiltration...
  30. ncbi Clinical and pathologic correlates in surgical stage II endometrial carcinoma
    David E Cohn
    Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, Ohio, USA
    Obstet Gynecol 109:1062-7. 2007
    ..To identify the surgical, pathologic, and therapeutic factors that influence outcome in patients with surgical stage II endometrial adenocarcinoma...
  31. doi Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus
    Warner K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 117:248-54. 2010
    ..This multi-institutional phase II trial assessed the activity and toxicity of imatinib mesylate and explored c-Kit and platelet-derived growth factor receptor (PDGFR)-beta in recurrent or persistent uterine carcinosarcoma...
  32. ncbi Hormonal contraception and false-positive cervical cytology: is there an association?
    Anna V Hoekstra
    Department of Obstetrics and Gynecology, Illinois Masonic Medical Center, Chicago, USA
    J Low Genit Tract Dis 10:102-6. 2006
    ..The aim of the study was to determine if use of hormonal contraception influences the false-positive rate of cervical cytology when compared with loop electrosurgical excision procedure or cervical biopsy specimens...
  33. ncbi A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer
    Ronald D Alvarez
    Department of Obstetrics, University of Alabama at Birmingham Cancer Center, Birmingham, Alabama 35233, USA
    Clin Cancer Res 8:2806-11. 2002
    ..The purpose of this study was to determine the feasibility and maximum tolerated dose of (90)Yttrium-CC49 ((90)Y-CC49) as the radioimmunotherapy (RIT) component of an i.p. combined modality treatment for recurrent ovarian cancer...
  34. ncbi Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia?
    Kellie S Matthews
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    J Low Genit Tract Dis 11:69-72. 2007
    ..Our objective was to determine the incidence of cervical intraepithelial neoplasia (CIN) 2,3 and patient factors that increase the likelihood of detecting CIN 2,3...
  35. ncbi A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    T Michael Numnum
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35294 7333, USA
    J Low Genit Tract Dis 9:2-6. 2005
    ..The objective of this study was to determine the incidence of CIN 2 and CIN 3 in patients with an HSIL (CIN 2) Pap smear using a see-and-treat protocol...
  36. doi Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomy
    Leigh G Seamon
    Divisions of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, USA
    Obstet Gynecol 114:16-21. 2009
    ..To compare adequacy and outcomes of surgical staging for endometrial cancer in obese women by robotics or laparotomy...
  37. ncbi Postmenopausal uterine inversion associated with endometrial polyps
    Rod Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Obstet Gynecol 102:521-3. 2003
    ..Postmenopausal uterine inversion is an extremely rare gynecologic complication. We report a case of uterine inversion associated with endometrial polyps alone...
  38. ncbi Gene therapy
    Warner K Huh
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Cancer Treat Res 107:133-57. 2002
  39. ncbi Cytology versus high-risk HPV testing for follow-up of HPV-positive women without CIN
    Kristopher J Kimball
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, 618 South 19th Street, OHB 538, Birmingham, Alabama 35249, USA
    J Natl Compr Canc Netw 6:96-100. 2008
    ..This article presents a brief overview of related guidelines and current modalities, and reviews selected studies. Finally, future directions and a possible schema for clinical management of these patients are included...
  40. doi The current and future role of screening in the era of HPV vaccination
    Evan Myers
    Division of Clinical and Epidemiological Research, Department of Obstetrics and Gynecology, DUMC 3279, 244 Baker House, Duke University Medical Center, Durham, NC 27710, USA
    Gynecol Oncol 109:S31-9. 2008
    ....
  41. ncbi Treatment considerations in advanced endometrial cancer
    James E Kendrick
    Division of Gynecologic Oncology, University of Alabama at Birmingham, 618 20th Street South, OHB Room 538, Birmingham, AL 35233, USA
    Curr Oncol Rep 9:494-8. 2007
    ..Over the past 10 years, the role of cytoreductive surgery, radiotherapy, and chemotherapy in endometrial cancer have been actively investigated. This review outlines and summarizes some of these important developments and findings...
  42. ncbi Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia
    James E Kendrick
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL 35249 7333, USA
    J Low Genit Tract Dis 11:25-8. 2007
    ..A pilot study to determine genomic microarray differences in patients with normal cervical tissue and cervical intraepithelial neoplasia (CIN) 3...
  43. ncbi Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series
    Charles A Leath
    Division of Gynecologic Oncology, University of Alabama at Birmingham, USA
    J Reprod Med 49:71-5. 2004
    ..To evaluate the incidence of c-kit expression in uterine sarcomas...
  44. ncbi A multi-institutional review of outcomes of endometrial stromal sarcoma
    Charles A Leath
    Department of Obstetrics, Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 105:630-4. 2007
    ..To compare the clinical behavior and outcomes of low- and high-grade endometrial stromal sarcomas (LGESS and HGESS), respectively...
  45. ncbi Optical detection of cervical neoplasia: results from an internally-controlled multicenter study
    Warner K Huh
    Division of Gynecologic Oncology, University of Alabama at Birmingham, AL 35294 7333, USA
    Gynecol Oncol 99:S53. 2005
  46. ncbi A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, AL 35294, USA
    Gynecol Oncol 104:591-5. 2007
    ..To determine the response rate, progression-free survival and toxicity associated with weekly topotecan administered to patients with platinum-sensitive recurrent epithelial ovarian (EOC) in the third-line setting...
  47. ncbi A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer
    Ashley S Case
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
    Obstet Gynecol 108:1375-9. 2006
    ..To prospectively evaluate in a blinded fashion the accuracy of frozen section in endometrial cancer...
  48. ncbi Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture
    Rebecca J Howard
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Obstet Gynecol 100:1061-3. 2002
    ..Pelvic hemorrhage continues to be a serious complication of pregnancy and can lead to significant maternal morbidity. The pelvic umbrella pack is a useful alternative to control pelvic bleeding when standard measures fail...
  49. ncbi Uterine leiomyosarcoma metastatic to the thyroid
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35249 7333, USA
    Obstet Gynecol 100:1122-4. 2002
    ..Uterine leiomyosarcoma is an aggressive tumor that has a propensity for distant metastasis. Distant sites of spread include the lung, liver, brain, and bone...
  50. ncbi Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: a polymerase chain reaction-based evaluation
    Jacob M Estes
    Division of Gynecologic Oncology, The University of Alabama Birmingham, Birmingham, AL 35249, USA
    J Low Genit Tract Dis 11:12-7. 2007
    ..To determine whether autoclave sterilization eradicates human papillomavirus (HPV) DNA on specula and instruments used to treat women with cervical neoplasia...
  51. ncbi A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis
    Mack N Barnes
    Department of Gynecologic Oncology, University of Alabama at Birmingham, 538 Old Hillman Building, 618 South 20th Street, Birmingham, AL 35233, USA
    Gynecol Oncol 87:57-63. 2002
    ..This study was performed to determine the ability of medroxyprogesterone acetate (Depo-Provera) to reduce the frequency of spontaneously developing reproductive tract adenocarcinoma in the avian model...
  52. ncbi Protrusio acetabuli presenting as a complex pelvic mass after total hip arthroplasty
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Obstet Gynecol 104:1187-9. 2004
    ..The differential diagnosis in an elderly woman with a complex pelvic mass includes benign and malignant diseases...
  53. doi Initial lessons learned in HPV vaccination
    Thomas J Herzog
    Columbia University, College of Physicians and Surgeons, Department of Obstetrics and Gynecology, 161 Fort Washington Avenue, 8th Floor New York, NY 10032, USA
    Gynecol Oncol 109:S4-11. 2008
    ..This article also examines the impact of the HPV vaccination awareness campaign on media and public policy dynamics...
  54. doi How does public policy impact cervical screening and vaccination strategies?
    Thomas J Herzog
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 119:175-80. 2010
    ..To examine the current approaches to cervical screening and points to consider for improving HPV vaccination acceptance and uptake in the US...
  55. ncbi Cervical cancer
    Benjamin E Greer
    J Natl Compr Canc Netw 6:14-36. 2008
  56. ncbi Carcinosarcoma of the ovary-a case series
    Teresa L Rutledge
    University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Gynecol Oncol 100:128-32. 2006
    ..To evaluate our experience with ovarian carcinosarcoma and identify prognostic factors...
  57. pmc Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination
    Chih Wen Tseng
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Clin Cancer Res 14:3185-92. 2008
    ....
  58. doi Age considerations when vaccinating against HPV
    Thomas C Wright
    Columbia University, New York, New York 10032, USA
    Gynecol Oncol 109:S40-7. 2008
    ..This review discusses the various considerations that should be addressed when making recommendations of who should be vaccinated against HPV...

Research Grants3

  1. A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
    WARNER KING HUH; Fiscal Year: 2010
    ..coli, may have a substantial global impact, particularly in developing nations and low resource settings where 80% of cervical cancer occurs. ..